z-logo
open-access-imgOpen Access
The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
Author(s) -
Panagiotis Theofilis,
Aikaterini Vordoni,
Rigas Kalaitzidis
Publication year - 2022
Publication title -
american journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 85
eISSN - 1421-9670
pISSN - 0250-8095
DOI - 10.1159/000525441
Subject(s) - melatonin , medicine , endocrinology , insulin resistance , kidney disease , type 2 diabetes , diabetes mellitus , pathophysiology of hypertension , pineal gland , blood pressure
The increasing incidence of chronic kidney disease (CKD), as a consequence of the high prevalence of arterial hypertension and type 2 diabetes mellitus (T2DM), warrants the need for developing effective treatment approaches. In this regard, the pineal gland-derived hormone melatonin may represent an appealing treatment approach of CKD and its associated risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here